New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Actuate Therapeutics, Inc. (ACTU) vs Dyadic International Inc. (DYAI)
- Actuate Therapeutics, Inc. ACTU 0.23 +9.52%
- Dyadic International Inc. DYAI 0.29 −6.45%
Actuate Therapeutics, Inc. and Dyadic International Inc. are both Biotechnology companies. Actuate Therapeutics, Inc. and Dyadic International Inc. are of similar size ($12.9M and $12.5M). Across the 8 metrics below, Dyadic International Inc. leads on 6 and Actuate Therapeutics, Inc. on 2.
Valuation
Profitability
| Metric | ACTU | DYAI | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 17.85% | 70.18% |
| Operating margin | — | (237.12%) | 0.00% |
| Net margin | — | (226.87%) | 0.00% |
| Free cash flow margin | — | (227.93%) | 0.00% |
| Return on equity | (364.70%) | (47,316.89%) | (51.58%) |
| Return on assets | (176.44%) | (71.43%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack